当前位置:首页 - 行情中心 - 中国医药(600056) - 财务分析

中国医药

(600056)

  

流通市值:168.83亿  总市值:168.88亿
流通股本:14.95亿   总股本:14.96亿

中国医药(600056)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2024年第一季度实现净利润2.03亿元,每股收益0.10元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2024年第一季度最新股东权益1409186.77万元,未分配利润759276.24万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2024年第一季度最新总资产3742507.73万元,负债2333320.96万元。

利润表
报告期2024-03-312023-12-312023-09-302023-06-30
营业总收入8,774,845,924.5738,824,430,504.8529,796,767,468.521,624,971,226.54
营业总成本8,513,876,388.4137,501,895,075.8628,684,951,933.5620,720,802,502.03
营业利润275,532,249.931,672,334,222.651,105,488,870.09873,142,857.99
利润总额273,566,147.941,640,555,520.81,109,150,508.67874,300,636.47
净利润202,880,820.281,242,120,464.96783,662,782.78676,753,330.14
其他综合收益1,361,482.42-40,686,616.87706,621.641,619,270.62
综合收益总额204,242,302.71,201,433,848.09784,369,404.42678,372,600.76
资产负债表
报告期2024-03-312023-12-312023-09-302023-06-30
流动资产合计28,522,113,442.5428,526,182,765.4429,069,805,205.2430,359,190,079.01
非流动资产合计8,902,963,877.378,883,729,456.849,116,399,770.669,098,138,315.76
资产总计37,425,077,319.9137,409,912,222.2838,186,204,975.939,457,328,394.77
流动负债合计18,521,658,307.6918,003,301,734.4819,038,386,996.0819,834,099,238.75
非流动负债合计4,811,551,265.225,518,985,043.55,459,498,840.925,983,836,541.42
负债合计23,333,209,572.9123,522,286,777.9824,497,885,83725,817,935,780.17
归属于母公司股东权益合计11,707,509,581.8611,560,548,147.4511,189,878,36711,140,228,113.46
股东权益合计14,091,867,74713,887,625,444.313,688,319,138.913,639,392,614.6
负债和股东权益合计37,425,077,319.9137,409,912,222.2838,186,204,975.939,457,328,394.77
现金流量表
报告期2024-03-312023-12-312023-09-302023-06-30
经营活动现金流入小计8,379,859,623.5341,746,686,056.9431,194,325,174.5521,437,689,929.57
经营活动现金流出小计9,586,529,531.0840,887,610,604.5231,528,464,465.6422,043,905,036.54
经营活动产生的现金流量净额-1,206,669,907.55859,075,452.42-334,139,291.09-606,215,106.97
投资活动现金流入小计95,20046,305,294.5534,854,631.9334,803,799.03
投资活动现金流出小计88,367,249.61362,552,304.58262,523,592.54147,933,964
投资活动产生的现金流量净额-88,272,049.61-316,247,010.03-227,668,960.61-113,130,164.97
筹资活动现金流入小计2,685,103,630.733,898,419,137.573,599,631,482.123,314,631,481.92
筹资活动现金流出小计2,447,929,143.044,624,073,630.14,102,397,721.753,202,413,751.33
筹资活动产生的现金流量净额237,174,487.69-725,654,492.53-502,766,239.63112,217,730.59
汇率变动对现金及现金等价物的影响13,495,949.262,040,757.423,132,252.11-3,899,436.5
现金及现金等价物净增加额-1,044,271,520.21-180,785,292.72-1,061,442,239.22-611,026,977.85
期末现金及现金等价物余额2,285,987,418.563,330,258,938.772,449,601,992.272,900,017,253.64
TOP↑